Fesoterodine fumarate 4 mg Tablet, Extended Release, 31,250-count — NDC 16262-001-01 (Billing 16262-0001-01)
This is a package of 31,250 tablets of Fesoterodine fumarate 4 mg Tablet, Extended Release from Aesica Pharmaceuticals GmbH, first listed with the FDA Oct 2008 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 16262-001-01 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 16262 labeler · 001 product · 01 package
- Package marketed since
- Oct 31, 2008
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 1626200101 4
- FDA record last changed
- Jul 24, 2026
Other active recalls for Fesoterodine Fumarate (different manufacturers) — 2 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats overactive bladder in adults, which means sudden urges to urinate, leaking with those urges, and going often. Some products, including Toviaz, are also approved for neuro...
- Take one tablet by mouth once a day, with or without food. Swallow it whole with liquid. Don't chew, split, or crush it because it's an extended-release tablet. Follow the dose you...
- Dry mouth is the most common, and constipation is next. Some people get indigestion, dry eyes, or a urinary tract infection. Call your doctor if side effects bother you or you have...
- Get help right away if your face, lips, tongue, or throat swells, because that's angioedema and it can block breathing. It can show up after the first dose or later. Stop the medic...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Fesoterodine Fumarate — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 16262-0001-01 You're viewing this Main listing | 1 BAG in 1 PAIL / 31250 TABLET, EXTENDED RELEASE in 1 BAG | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Fesoterodine Fumarate 4 mg 31722-0033-30 | Camber | 30 tablets | $0.777 | AB | Availability likely | — |
| Fesoterodine Fumarate 4 mg 67877-0064-30 | Ascend | 30 tablets | $0.777 | AB | Availability likely | — |
| Fesoterodine Fumarate 4 mg 72603-0413-01 | NorthStar | 30 tablets | $0.777 | AB | Availability likely | — |
| Fesoterodine Fumarate 4 mg 65862-0766-30 | Aurobindo | 30 tablets | $0.777 | AB | Availability likely | — |
| Fesoterodine fumarate 4 mg 43598-0247-30 | Dr.Reddy's | 30 tablets | $0.777 | AB | Availability likely | — |
| fesoterodine fumarate 4 mg 68382-0479-06 | Zydus | 30 tablets | $0.777 | AB | Availability likely | — |
| Toviaz 4 mg 00069-0242-30 | Pfizer | 30 tablets | $9.296 | AB | Availability likely | — |
| Fesoterodine Fumarate 4 mg 46708-0175-10 | Alembic | 100 tablets | — | AB | FDA listed | — |
| Fesoterodine fumarate 4 mgthis 16262-0001-01 | Aesica | 31250 tablets | — | — | FDA listed | — |
| Fesoterodine Fumarate 4 mg 65162-0369-03 | Amneal | 30 tablets | — | AB | FDA listed | — |
| Fesoterodine fumarate 4 mg 51407-0661-30 | Golden | 30 tablets | — | AB | FDA listed | — |
| Fesoterodine Fumarate 4 mg 62332-0175-10 | Alembic | 100 tablets | — | AB | FDA listed | — |
| fesoterodine fumarate 4 mg 70771-1168-03 | Zydus | 30 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Fesoterodine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Aesica Pharmaceuticals GmbH labeler code 16262
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Aesica Pharmaceuticals GmbH supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |